Navigation Links
MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting

epitant given only on Day 1 for the prevention of acute and delayed CINV in patients receiving MEC were presented in a poster session on Saturday, June 2, 2007.

Forty-one patients (40 female, 1 male) with solid tumors received a 1-day, 3-drug regimen of intravenous Aloxi 0.25 mg, oral dexamethasone 20 mg and aprepitant 285 mg prior to their first cycle of chemotherapy. Endpoints of the study included complete response (no emesis or rescue medication), no emesis, and no significant nausea (Visual Analogue Score (VAS; 0-100) less than 25) on Day 1, during the delayed period of Days 2-5, and during the overall period of Days 1-5.

On Day 1, 100% of patients had no emesis and at least 95% of patients had no emetic episodes in the delayed and overall time periods. A complete response was demonstrated in 75% of patients on Day 1 and in 67% of patients in the delayed time period. Based on VAS, the majority of patients had no significant nausea in the acute, delayed or overall phases. The most commonly observed adverse events were headache and fatigue.

Phase 3 Results of Aloxi in Pediatric Patients

The results of a phase 3, multicenter, randomized, double-blind study to assess the safety, efficacy and pharmacokinetics of single intravenous doses of Aloxi in pediatric patients were presented in a poster session on Sunday, June 3, 2007. Sixty patients (2-17 years of

age) were randomized to receive either 3 mcg/kg or 10 mcg/kg with a maximum total dose of 0.25 mg and 0.75mg, respectively, prior to moderately (n=21) or highly (n=39) emetogenic chemotherapy. Twelve additional patients, age 28 days-23 months, were studied in open-label design at the same doses. The majority of patients had received previous chemotherapy. Day 1 complete response (CR: no emetic episodes and no rescue medication) rates of 37.1% (CI, 22.0-55.1%) and 54.1% (CI, 37.1-70.2%) were reported in the 3 mcg/kg (n=35) and 10 mcg/kg

(n=37) groups, respectively. The perce
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/6/2009)...OAKLAND, Calif., Nov. 6 Kaiser Fou...tals (KFHP/H), and their subsidiaries reported tod...lion for the quarter ended September 30, 2009, com...t year. Operating income in the third quarter was ...d quarter of last year. Net non-operating income w...
(Date:11/6/2009)...WASHINGTON, Nov. 6 Amer...ormal working group of mid-market and smaller inno...ncerns about H.R. 3962, the "Affordable Health Car...last Thursday. These smaller companies fear that ....R. 3962 will hinder their efforts to bring new me...
(Date:11/6/2009)...LEXINGTON, Ky., Nov. 6 V...rd: VHGI) confirmed today that the previously conf...ated assets to Wound Management Technologies, Inc ...of Directors and shareholders of VHGI. ,, Sh...otential stock dividend, royalty stream and cash r...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Biosimilars of Rituxan MabThera Herceptin and Erbitux will Erode 248 2 Billion in U S and European Sales in 2018 57220 1Biosimilars of Rituxan MabThera Herceptin and Erbitux will Erode 248 2 Billion in U S and European Sales in 2018 57220 2Biosimilars of Rituxan MabThera Herceptin and Erbitux will Erode 248 2 Billion in U S and European Sales in 2018 57220 3Gene Switch May Help Drive Excess Fluid in Lungs 57218 1Early Spankings Make for Aggressive Toddlers Study Shows 57216 1Early Spankings Make for Aggressive Toddlers Study Shows 57216 2Early Spankings Make for Aggressive Toddlers Study Shows 57216 3
...ore4Life Advanced Memory Formula(TM), PURCHASE, N... a developer and marketer of nutritional supplemen...improve cardiovascular health,enhance memory and a...ults,of a clinical study that showed daily supplem...colinate, increased brain activity in older adults...
...s Explorations to support bold, unconven...E, March 3 The Bill & Melinda Gates Foundation,an...ll accept grant,proposals for the first funding ro... million initiative to help scientists across the ...ted for solving major health problems.,The four to...
Other Medicine Technology:New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 2New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 3New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults 4Gates Foundation Seeks Proposals for Innovative Global Health Research 2Gates Foundation Seeks Proposals for Innovative Global Health Research 3
(Date:11/7/2009)...ewswire/ -- Speaker Nancy Pelosi spoke on the Hou...able Health Care for America Act. The House will ...the Speaker,s remarks. ,, "Madam Speaker, toda...ation and for American families. For nearly a cen...phy -- as far back as Teddy Roosevelt -- have call...
(Date:11/7/2009)...ng this a "defining moment" for the American Medic...ohack, M.D., today addressed medical students and ...alty societies at the opening of the AMA,s semi-an...form will top the agenda. ,, (Logo: http://ww..., "Over the next 72 hours, this AMA House of Del...
(Date:11/7/2009)...wire/ -- The U.S. bishops November 7 urged members...tupak-Ellsworth Amendment to the health care refor...mper-Lipinski-Smith Amendment will keep in place c...nce protections in the Affordable Health Care for ...ter was signed by Cardinal Justin Rigali, chair of...
(Date:11/7/2009)... rebel, expert says , , SATURDAY, Nov. 7 (... badly if their parents expect them to, a new U.S....simply being realistic might actually contribute t... psychology professor at Wake Forest University an...s release. "Negative expectations on the part of b...
(Date:11/7/2009)...tox’ or ‘Boytox’, the new trend ... jab ‘Breastox’ – or breast boto...e, can reduce the appearance of wrinkles and lift ...ving smoother, younger-looking skin. , ...m, the UK’s largest group of cosmetic surge...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:UK Boobs Get a Boost with 'Breastox' 2
... The following release was issued today by the Na...s after federal vaccine court ruled against three ...children, Huffington Post writers Robert F Kenne...ek, Banks, parents were awarded a lump sum of more...
...worker at a paper-recycling plant, fell through a ...as he was preparing to inspect a steam valve. Supe... degrees Fahrenheit, enveloped his legs instantly,...ft with first-, second- and third-degree burns on ...
...6 Most people accustomed to working within a mana... question the quality of their care or the cost of...charge until after a surgery when they get the bil...ings accounts (HSA) are growing in popularity. Yo...
...eb. 26 On Monday, March 2, the advertising and ...y to become "The Healthiest Company in Green Bay."...the area to beat them at that goal. , , The 30-pe...Company in Green Bay," is based on a list of key h...
... of education and cultural competence as keys to s...emy of Orthopaedic Surgeons ( http://www.aaos.o... has spent the majority of his life encouraging th...today with the Academy,s Diversity Award at its 20...
...ns aid orthopaedic surgeons in treating this commo...itis (OA) ( http://www.orthoinfo.org/topic.cfm?to...tis. It can affect any joint in the body particul... of the American Academy of Orthopaedic Surgeons ...
Other Medicine News:Health News:On the Heels of Court Ruling Denying Autism-Vaccine Link, U.S. Federal Court Declares MMR Vaccine Caused Autism in a Young Boy 2Health News:Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching 2Health News:Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 2Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 4Health News:Arketype to Become Green Bay's Healthiest Company in One Year -- Wanna Bet? 2Health News:Arketype to Become Green Bay's Healthiest Company in One Year -- Wanna Bet? 3Health News:Ramon L. Jimenez, MD: A Diverse Life 2Health News:Ramon L. Jimenez, MD: A Diverse Life 3Health News:An Orthopaedic Roadmap for Osteoarthritis of the Knee 2Health News:An Orthopaedic Roadmap for Osteoarthritis of the Knee 3
Sterivent® "S" (Compact) Filter
Barrierbac Filter
...; Thermovent® T helps provide protection to th...s small and extremely lightweight making it ideal ...a high rate of heat and moisture recovery, it ensu...n., ,All HMEs and filters have ISO standard taper...
...; Thermovent® T helps provide protection to th...s small and extremely lightweight making it ideal ...a high rate of heat and moisture recovery, it ensu...n., ,All HMEs and filters have ISO standard taper...
Medicine Products: